Our Response to COVID-19
As a science-based biopharmaceutical company, our mission is to improve the quality of human and animal life.
COVID-19 is an extraordinary challenge to the global community.
In the face of this extraordinary challenge, our company recognizes and applauds all those who are going above and beyond to do their part in helping affected patients and communities, especially the health care providers on the frontlines of this fight.
Citizens and organizations alike are doing their part in this truly global effort, including the biopharmaceutical industry. As a company dedicated to saving and improving lives, we recognize that we have a unique responsibility to help.
In response to the COVID-19 pandemic, we are focused on protecting the safety of our employees and their families, ensuring that our supply of medicines and vaccines reach our patients and customers, contributing our scientific expertise to the development of antiviral and vaccine approaches, and supporting healthcare providers and our communities.
Dr. Julie GerberdingExecutive Vice President and Chief Patient Officer
“It has been said that with COVID-19, no one is safe until everyone is safe. We care deeply about the human toll of this virus, and the patients and families who’ve been impacted. And yet we have good reason to be optimistic. The global mobilization to tackle this disease has been unprecedented, and working together, we are rising to the challenge.”